Accelerate Diagnostics, Inc.'s (AXDX) CEO Jack Phillips on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/16/22
Accelerate Diagnostics announces commercialization in Europe of its Accelerate Arc™ system having completed IVDR registrationPRNewsWire • 07/11/22
Accelerate Diagnostics to Participate in 42nd Annual William Blair Growth Stock Conference on June 7, 2022PRNewsWire • 05/23/22
Accelerate Diagnostics, Inc. (AXDX) CEO Jack Phillips on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/17/22
Accelerate Diagnostics (AXDX) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/16/22
Accelerate Diagnostics announces commercialization of its Accelerate Arc™ system having completed IVD registration with FDAPRNewsWire • 05/16/22
Accelerate Diagnostics Presents New Data at ECCMID 2022 Demonstrating Rapid and Accurate Results Using Automated Accelerate Arc™ Module and BC KitPRNewsWire • 04/25/22
Accelerate Diagnostics' (AXDX) CEO Jack Phillips on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/09/22
Accelerate Diagnostics (AXDX) Reports Q4 Loss, Tops Revenue EstimatesZacks Investment Research • 03/08/22
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2021 Financial ResultsPRNewsWire • 03/08/22
Accelerate Diagnostics scheduled call to review 2021 fourth quarter and full year resultsPRNewsWire • 02/24/22
Accelerate Diagnostics (AXDX) May Report Negative Earnings: Know the Trend Ahead of Q4 ReleaseZacks Investment Research • 02/15/22
Accelerate Diagnostics to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 16, 2022, at 10:00 a.m. Eastern TimePRNewsWire • 02/02/22
Accelerate Diagnostics Announces Preliminary Fourth Quarter & Full-Year 2021 Financial ResultsPRNewsWire • 01/13/22
Accelerate Diagnostics Wins Suzhou Innovation Award to Support Continued China Commercialization EffortsPRNewsWire • 01/12/22
Accelerate Diagnostics to Participate Virtually in 40th Annual J. P. Morgan Healthcare Conference on January 13, 2022PRNewsWire • 12/29/21